Immunotherapy associated Sweet syndrome in a patient with metastatic melanoma: A case report

• المؤلفون الرئيسيون: Rory Barry (مؤلف), Gregg Murray (مؤلف), Sally McGrath (مؤلف), Clive Kilgallen (مؤلف), Karen Eustace (مؤلف)
• التنسيق: كتاب
• منشور في: Wiley, 2024-09-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Immunotherapy agents are now widely used in the treatment of metastatic melanoma. Immune‐related adverse events (irAEs) may occur, including cutaneous pathologies in 50% of patients. We report a case of Sweet syndrome (SS) in a patient who was prescribed ipilimumab and nivolumab for metasta...